1.17 USD
0.000.00%
盘后 1.34 0.00%
2026-09-16
市值
$3.03M
市盈率
—
EPS
-33.30
股息率
—
52 周区间
1.17 – 27.84
成交量
30.09K
Beta
1.32
目标价
—
52W 低 1.1752W 高 27.84
价格走势
公司简介
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as Ne...